Task B05. 09/24/2018 - 11/23/2019.
Ended Awarded Last action
- Contract number
- 75N93018F00003
- Awardee
-
Bioqual, Inc. UEI CK9LGQ7EBNN8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,674,011
Award facts
- Opportunity
-
- NIHAI2016059 Solicitation number
- Contract value 100% obligated
- $2,674,011.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$25,489 | |
| Funding Only Action | $238,225 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $756,039 | |
| Original award | $1,705,236 |
About this award
This delivery order, awarded to Bioqual, Inc. on August 28, 2018, represents Task B05 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The $2.67 million cost-plus-fixed-fee award funds the development and refinement of a Neisseria gonorrhea infection model using pigtailed macaques (Macaca nemestrina) to advance prevention and control strategies for this sexually transmitted infection. The work was performed in Potomac, Maryland, with an ultimate completion date of September 30, 2020, and represents the National Institute of Allergy and Infectious Diseases' (NIAID) investment in preclinical research infrastructure for infectious disease countermeasures. No set-aside designation was applied to this award.
Bioqual, Inc., a biomedical research services company based in Rockville, Maryland, was selected to execute this non-human primate modeling research. The contractor specializes in providing advanced scientific research support to federal agencies, with particular expertise in animal studies and preclinical testing for NIAID and other National Institutes of Health institutes. This delivery order falls within the parent indefinite delivery contract framework that reflects NIAID's broader commitment to developing animal models for evaluating medical countermeasures, with Bioqual serving as a strategic partner in supporting complex, specialized research initiatives across multiple scientific domains including vaccine development and infectious disease research.
Quick answers
Who was awarded contract 75N93018F00003?
75N93018F00003 was awarded to Bioqual, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 28, 2018.
How much is contract 75N93018F00003 worth?
The government has obligated $2,674,011 on 75N93018F00003.
Is contract 75N93018F00003 an order under another contract?
Yes. 75N93018F00003 is a delivery order under HHSN272201700015I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93018F00003 competed?
The extent of competition for 75N93018F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award